Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Y. Hu, K. Ying (Hangzhou, China). The research on early detection of lung cancer with exhaled volatile organic compounds. Eur Respir J 2014; 44: Suppl. 58, 2766

Member's Comments

No comment yet.

Related content which might interest you: Exhaled breath temperature in NSCLC: Could be a new non invasive marker? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Early detection of lung cancer in exhaled breath condensate using miRNA markers Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Methilation status in EBUS-NA samples of lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Symptom-to-treatment intervals in lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 The value of miR221 and miR222 as a biomarker in non small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Improving NLST criteria for lung cancer screening Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Chemopreventive effect of phosphodieasterase-4 inhibition in benzo(a)pyrene-induced murine lung cancer model Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Detection of early stage lung cancer by electronic nose Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Relationship between risk factors for lung cancer and tumor size Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Co-exposure between asbestos and inorganic particles and risk of lung cancer in the ARDCO study Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Lung cancer in women: Is it different? Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Functional impairment of NK cells in non-small-cell lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Assessment of nutritional status in patients with primary lung cancer Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014